Inventors list |
Assignees list |
Classification tree browser |
Top 100 Inventors |
Top 100 Assignees |
Balázs
Balázs Havasi, Budapest HU
| Patent application number | Description | Published |
|---|---|---|
| 20100081668 | POLYMORPHS OF 5--6-CHLORO-1,3-DIHYDRO-2H-INDOL-2-ONE HYDROBROMIDE AND PROCESSES FOR PREPARATION THEREOF - The present invention provides pharmaceutically applicable compounds and polymorphs belonging to the ziprasidone hydrobromide compound group with antipsychotic effect. The present invention provides hydrobromide polymorphs of 5-{-2-[4-(1,2-benzisothiazol-3-yl)-1-piperazinyl]-ethyl}-6-chloro-1,3-dihydro-2H-indol-2-one, ziprasidone of Formula (I) having neuroleptic activity. | 04-01-2010 |
Balázs Havasi, Budapest HU
| Patent application number | Description | Published |
|---|---|---|
| 20100081668 | POLYMORPHS OF 5--6-CHLORO-1,3-DIHYDRO-2H-INDOL-2-ONE HYDROBROMIDE AND PROCESSES FOR PREPARATION THEREOF - The present invention provides pharmaceutically applicable compounds and polymorphs belonging to the ziprasidone hydrobromide compound group with antipsychotic effect. The present invention provides hydrobromide polymorphs of 5-{-2-[4-(1,2-benzisothiazol-3-yl)-1-piperazinyl]-ethyl}-6-chloro-1,3-dihydro-2H-indol-2-one, ziprasidone of Formula (I) having neuroleptic activity. | 04-01-2010 |
Balázs Matuz, Gilching DE
| Patent application number | Description | Published |
|---|---|---|
| 20090292966 | Method for recovery of lost and/or corrupted data - A method for recovery of lost and/or corrupted data transmitted from a transmitter device to a receiver device. The data is coded by an encoder connected to the transmitter device. The data is transmitted from the transmitter device to the receiver device via a transmission system and is decoded by means of a decoder connected to the receiver device. This is performed through application of a low density parity check method, wherein lost and/or corrupted data is restored during decoding. The decoding is performed by solving the equation system of the parity check matrix H. The parity check matrix H is brought into a triangular form by column and/or row permutations. Columns of a sub-matrix B of the matrix H which impede the triangulation process are shifted into a sub-matrix P of the matrix H so that the triangulation process can be continued until the matrix H except for the sub-matrix P has been completely brought into a triangular form. The Gaussian elimination method is applied to a part of the sub-matrix P. The selection of the column or columns of the sub-matrix B which are to be shifted into the sub-matrix P is performed on the basis of the weight of the column which corresponds to the number of non-zero-entries in the column, and/or on the basis of the weight of the rows of the sub-matrix B connected to the column. | 11-26-2009 |
Balázs Matuz, Gilching DE
| Patent application number | Description | Published |
|---|---|---|
| 20090292966 | Method for recovery of lost and/or corrupted data - A method for recovery of lost and/or corrupted data transmitted from a transmitter device to a receiver device. The data is coded by an encoder connected to the transmitter device. The data is transmitted from the transmitter device to the receiver device via a transmission system and is decoded by means of a decoder connected to the receiver device. This is performed through application of a low density parity check method, wherein lost and/or corrupted data is restored during decoding. The decoding is performed by solving the equation system of the parity check matrix H. The parity check matrix H is brought into a triangular form by column and/or row permutations. Columns of a sub-matrix B of the matrix H which impede the triangulation process are shifted into a sub-matrix P of the matrix H so that the triangulation process can be continued until the matrix H except for the sub-matrix P has been completely brought into a triangular form. The Gaussian elimination method is applied to a part of the sub-matrix P. The selection of the column or columns of the sub-matrix B which are to be shifted into the sub-matrix P is performed on the basis of the weight of the column which corresponds to the number of non-zero-entries in the column, and/or on the basis of the weight of the rows of the sub-matrix B connected to the column. | 11-26-2009 |
Balázs Sarkadi, Budapest HU
| Patent application number | Description | Published |
|---|---|---|
| 20100021927 | CHOLESTEROL LOADED INSECT CELL MEMBRANES AS TEST SYSTEMS FOR ABC TRANSPORTER PROTEINS - The invention provides for a novel cholesterol loaded insect cell membrane preparation having an increased cholesterol level as compared to physiological cholesterol levels of insect cell membranes or to control insect cell membrane preparations without cholesterol loading, wherein said cholesterol loaded membrane preparation comprises an ABC transporter protein having an increased substrate transport activity due to increased cholesterol level of the membrane. The invention also relates to reagent kits comprising the preparations of the invention. The invention also relates to methods for manufacturing said preparations and methods for measuring any type of activity of the ABC transporters present in the cholesterol loaded membranes as well as studying or testing compounds and interaction of compounds and ABC transporters, in this assay systems. The invention also provides for a test system useful for testing whether ABC transporter proteins can be activated by cholesterol in an insect cell membrane. | 01-28-2010 |
| 20100255505 | GENETICALLY MODIFIED STEM CELLS AND METHODS FOR IDENTIFYING TISSUES DIFFERENTIATED THEREFROM - Genetically modified stem cells and the selection of cells differentiated therefrom are disclosed. Particularly, the herein disclosed invention relates to stem cells or cells differentiated therefrom containing a copy of a stably inheritable expression construct that is suitable for the expression of transgenes in stem cells, wherein said construct comprises at least a double-feature constitutive promoter being operable both in stem cells and in differentiated tissues, the expression level thereof being subject to a tissue or cell type specific regulation in differentiated cells, and, optionally, under the control of said promoter, a transgene, wherein said transgene is expressed in the stem cell. Furthermore methods are disclosed to produce such stem cells, as well as specific uses of said stem cells in assay methods and in human therapy and in veterinary practice. | 10-07-2010 |
Balázs Sarkadi, Budapest HU
| Patent application number | Description | Published |
|---|---|---|
| 20100021927 | CHOLESTEROL LOADED INSECT CELL MEMBRANES AS TEST SYSTEMS FOR ABC TRANSPORTER PROTEINS - The invention provides for a novel cholesterol loaded insect cell membrane preparation having an increased cholesterol level as compared to physiological cholesterol levels of insect cell membranes or to control insect cell membrane preparations without cholesterol loading, wherein said cholesterol loaded membrane preparation comprises an ABC transporter protein having an increased substrate transport activity due to increased cholesterol level of the membrane. The invention also relates to reagent kits comprising the preparations of the invention. The invention also relates to methods for manufacturing said preparations and methods for measuring any type of activity of the ABC transporters present in the cholesterol loaded membranes as well as studying or testing compounds and interaction of compounds and ABC transporters, in this assay systems. The invention also provides for a test system useful for testing whether ABC transporter proteins can be activated by cholesterol in an insect cell membrane. | 01-28-2010 |
| 20100255505 | GENETICALLY MODIFIED STEM CELLS AND METHODS FOR IDENTIFYING TISSUES DIFFERENTIATED THEREFROM - Genetically modified stem cells and the selection of cells differentiated therefrom are disclosed. Particularly, the herein disclosed invention relates to stem cells or cells differentiated therefrom containing a copy of a stably inheritable expression construct that is suitable for the expression of transgenes in stem cells, wherein said construct comprises at least a double-feature constitutive promoter being operable both in stem cells and in differentiated tissues, the expression level thereof being subject to a tissue or cell type specific regulation in differentiated cells, and, optionally, under the control of said promoter, a transgene, wherein said transgene is expressed in the stem cell. Furthermore methods are disclosed to produce such stem cells, as well as specific uses of said stem cells in assay methods and in human therapy and in veterinary practice. | 10-07-2010 |
Balázs Sümegi, Pecs HU
| Patent application number | Description | Published |
|---|---|---|
| 20100311719 | Prevention of Obesity in Antipsychotic, Antidepressant and Antiepileptic Medication - O-(3-piperidino-2-hydroxypropyl)-nicotinic amidoxime or a pharmaceutically suitable acid addition salt thereof (BGP-15) can be used for the prevention or reduction of weight gain or obesity in a patient treated with an antipsychotic drug or an antidepressant drug or an antiepileptic drug. | 12-09-2010 |
| 20110098255 | COMBINATION OF A PARP INHIBITOR AND AN AKT KINASE ACTIVATING COMPOUND - The primary subject of the invention is the use of a PARP inhibitor and an Akt kinase activating compound in combination in the treatment of pathological conditions related to PARP activation and/or that could benefit from Akt activation. A further subject of the invention is the use of a PARP inhibitor and an Akt kinase activating compound in combination for the preparation of pharmaceutical composition or kit for the treatment of a pathological condition related to PARP activation. The invention also relates to pharmaceutical composition, which contains a PARP-inhibitor and an Akt kinase activating compound together with auxiliaries generally used in pharmacy. | 04-28-2011 |
Balázs Sümegi, Pecs HU
| Patent application number | Description | Published |
|---|---|---|
| 20100311719 | Prevention of Obesity in Antipsychotic, Antidepressant and Antiepileptic Medication - O-(3-piperidino-2-hydroxypropyl)-nicotinic amidoxime or a pharmaceutically suitable acid addition salt thereof (BGP-15) can be used for the prevention or reduction of weight gain or obesity in a patient treated with an antipsychotic drug or an antidepressant drug or an antiepileptic drug. | 12-09-2010 |
| 20110098255 | COMBINATION OF A PARP INHIBITOR AND AN AKT KINASE ACTIVATING COMPOUND - The primary subject of the invention is the use of a PARP inhibitor and an Akt kinase activating compound in combination in the treatment of pathological conditions related to PARP activation and/or that could benefit from Akt activation. A further subject of the invention is the use of a PARP inhibitor and an Akt kinase activating compound in combination for the preparation of pharmaceutical composition or kit for the treatment of a pathological condition related to PARP activation. The invention also relates to pharmaceutical composition, which contains a PARP-inhibitor and an Akt kinase activating compound together with auxiliaries generally used in pharmacy. | 04-28-2011 |
Balázs Székely, Budapest HU
| Patent application number | Description | Published |
|---|---|---|
| 20110277009 | Supporting Functions for Quality-Assured P2P VOD Services - The present invention relates to a method for controlling downloading of video segments or segmented video stream to a subscriber client unit, and a subscriber client unit adapted to perform said method. One object of the invention is to guarantee seamless playback and the optimal server load. Said object is by a method and a subscriber client unit that is controlled by a segment selector (SSA) and a server bandwidth control (SBC) algorithm. | 11-10-2011 |
Balázs Tolnai, Montreal CA
| Patent application number | Description | Published |
|---|---|---|
| 20100124651 | METHOD OF MANUFACTURING NANO-CRYSTALLINE CELLULOSE FILM - The present invention provides a method of manufacturing a film containing nano-crystalline cellulose. | 05-20-2010 |
Balázs Tolnai, Montreal CA
| Patent application number | Description | Published |
|---|---|---|
| 20100124651 | METHOD OF MANUFACTURING NANO-CRYSTALLINE CELLULOSE FILM - The present invention provides a method of manufacturing a film containing nano-crystalline cellulose. | 05-20-2010 |